These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15143471)

  • 1. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
    Arenas JI; Gallegos-Orozco JF; Laskus T; Wilkinson J; Khatib A; Fasola C; Adair D; Radkowski M; Kibler KV; Nowicki M; Douglas D; Williams J; Netto G; Mulligan D; Klintmalm G; Rakela J; Vargas HE
    J Infect Dis; 2004 Jun; 189(11):2037-46. PubMed ID: 15143471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.
    Guerrero RB; Batts KP; Burgart LJ; Barrett SL; Germer JJ; Poterucha JJ; Wiesner RH; Charlton MR; Persing DH
    Mod Pathol; 2000 Mar; 13(3):229-37. PubMed ID: 10757333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
    Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence variation in the hypervariable region 1 of hepatitis C virus and posttransplantation recurrent hepatitis.
    Silini E; Belli L; Brambilla S; Foti L; Gritti C; Lisa A; Alberti AB; Vinci M; De Carlis L; Rondinara G; Pinzello G
    Liver Transpl; 2003 Oct; 9(10):1040-7. PubMed ID: 14526398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.
    Lyra AC; Fan X; Di Bisceglie AM
    Braz J Infect Dis; 2004 Apr; 8(2):126-32. PubMed ID: 15361990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
    Alkhouri N; Hanouneh IA; Lopez R; Zein NN
    Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.
    Rosen HR; Gretch D; Kaufman E; Quan S
    Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.
    Schvoerer E; Soulier E; Royer C; Renaudin AC; Thumann C; Fafi-Kremer S; Brignon N; Doridot S; Meyer N; Pinson P; Ellero B; Woehl-Jaegle ML; Meyer C; Wolf P; Zachary P; Baumert T; Stoll-Keller F
    J Infect Dis; 2007 Aug; 196(4):528-36. PubMed ID: 17624837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
    Zimmermann T; Otto C; Hoppe-Lotichius M; Biesterfeld S; Lautem A; Knaak M; Zimmermann A; Barreiros AP; Heise M; Schattenberg JM; Sprinzl MF; Galle PR; Otto G; Schuchmann M
    Transplant Proc; 2009; 41(6):2549-56. PubMed ID: 19715972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation.
    Pelletier SJ; Raymond DP; Crabtree TD; Iezzoni JC; Sawyer RG; Hahn YS; Pruett TL
    Hepatology; 2000 Aug; 32(2):375-81. PubMed ID: 10915745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation.
    Mas V; Maluf D; Archer KJ; Potter A; Suh J; Gehrau R; Descalzi V; Villamil F
    Liver Transpl; 2011 Jul; 17(7):824-35. PubMed ID: 21618696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy.
    Blackard JT; Yang Y; Bordoni P; Sherman KE; Chung RT;
    J Infect Dis; 2004 Apr; 189(8):1472-81. PubMed ID: 15073685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.